Borot, F., Humbert, O., Ehmsen, J. T., Fields, E., Kohli, S., Radtke, S., Swing, K., Pande, D., Enstrom, M. R., Laszlo, G. S., Mayuranathan, T., Ali, A. M., Weiss, M. J., Yen, J. S., Newby, G. A., Walter, R. B., Liu, D. R., Mukherjee, S., & Kiem, H.-P. (2025). Multiplex base editing to protect from CD33 directed drugs for immune and gene therapy. Nature Communications, 16(1). https://doi.org/10.1038/s41467-025-59713-2

Godbout, K., Dugas, M., Reiken, S. R., Ramezani, S., Falle, A., Rousseau, J., Wronska, A. E., Lamothe, G., Canet, G., Lu, Y., Planel, E., Marks, A. R., & Tremblay, J. P. (2025). Universal Prime Editing Therapeutic Strategy for RyR1-Related Myopathies: A Protective Mutation Rescues Leaky RyR1 Channel. International Journal of Molecular Sciences, 26(7), 2835. https://doi.org/10.3390/ijms26072835

Maniatis, T. (2024). From bacterial operons to gene therapy: 50 years of the journal Cell. Cell, 187(23), 6417–6420. https://doi.org/10.1016/j.cell.2024.10.037

Zuccaro, M. V., LeDuc, C. A., & Thaker, V. V. (2024). Updates on Rare Genetic Variants, Genetic Testing, and Gene Therapy in Individuals With Obesity. Current Obesity Reports, 13(3), 626–641. https://doi.org/10.1007/s13679-024-00567-y

Abela, L., Gianfrancesco, L., Tagliatti, E., Rossignoli, G., Barwick, K., Zourray, C., Reid, K. M., Budinger, D., Ng, J., Counsell, J., Simpson, A., Pearson, T. S., Edvardson, S., Elpeleg, O., Brodsky, F. M., Lignani, G., Barral, S., & Kurian, M. A. (2024). Neurodevelopmental and synaptic defects in DNAJC6 parkinsonism, amenable to gene therapy. Brain, 147(6), 2023–2037. https://doi.org/10.1093/brain/awae020

Breazzano, M. P., Batson, S. A., Tsang, S. H., & Chen, R. W. S. (2022). Surgical Approach with Pars Plana Vitrectomy for Subretinal Gene Therapy. Retinitis Pigmentosa, 393–399. https://doi.org/10.1007/978-1-0716-2651-1_35

Wu, W.-H., Tso, A., Breazzano, M. P., Jenny, L. A., Levi, S. R., Tsang, S. H., & Quinn, P. M. J. (2022). Culture of Human Retinal Explants for Ex Vivo Assessment of AAV Gene Delivery. Retinitis Pigmentosa, 303–311. https://doi.org/10.1007/978-1-0716-2651-1_28

Pereira, E. M. (2022). Gene Therapy Update. Pediatrics In Review, 43(9), 536–537. https://doi.org/10.1542/pir.2021-005091

Kajtna, J., Tsang, S. H., & Koch, S. F. (2022). Late-stage rescue of visually guided behavior in the context of a significantly remodeled retinitis pigmentosa mouse model. Cellular and Molecular Life Sciences, 79(3). https://doi.org/10.1007/s00018-022-04161-0

Kanter, J., Walters, M. C., Krishnamurti, L., Mapara, M. Y., Kwiatkowski, J. L., Rifkin-Zenenberg, S., Aygun, B., Kasow, K. A., Pierciey, F. J., Bonner, M., Miller, A., Zhang, X., Lynch, J., Kim, D., Ribeil, J.-A., Asmal, M., Goyal, S., Thompson, A. A., & Tisdale, J. F. (2022). Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease. New England Journal of Medicine, 386(7), 617–628. https://doi.org/10.1056/nejmoa2117175

Thomsen, G., Burghes, A. H. M., Hsieh, C., Do, J., Chu, B. T. T., Perry, S., Barkho, B., Kaufmann, P., Sproule, D. M., Feltner, D. E., Chung, W. K., McGovern, V. L., Hevner, R. F., Conces, M., Pierson, C. R., Scoto, M., Muntoni, F., Mendell, J. R., & Foust, K. D. (2021). Biodistribution of onasemnogene abeparvovec DNA, mRNA and SMN protein in human tissue. Nature Medicine, 27(10), 1701–1711. https://doi.org/10.1038/s41591-021-01483-7

Lopez‐Gomez, C., Sanchez‐Quintero, M. J., Lee, E. J., Kleiner, G., Tadesse, S., Xie, J., Akman, H. O., Gao, G., & Hirano, M. (2021). Synergistic Deoxynucleoside and Gene Therapies for Thymidine Kinase 2 Deficiency. Annals of Neurology, 90(4), 640–652. Portico. https://doi.org/10.1002/ana.26185